Get the Stockscreener App
1.40
0.00%
0.00
Pre-market:
1.41
0.01
+0.71%
Intercure Ltd stock is traded at $1.40, with a volume of 11,609.
It is up +0.00% in the last 24 hours and down -14.63% over the past month.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.
See More
Previous Close:
$1.40
Open:
$1.41
24h Volume:
11,609
Relative Volume:
0.18
Market Cap:
$76.32M
Revenue:
$118.18M
Net Income/Loss:
$5.99M
P/E Ratio:
10.61
EPS:
0.1319
Net Cash Flow:
$-12.91M
1W Performance:
-7.28%
1M Performance:
-14.63%
6M Performance:
-11.05%
1Y Performance:
-18.60%
1-Day Range:
$1.38
$1.41
1-Week Range:
$1.32
$1.52
52-Week Range:
$1.17
$1.79
Intercure Ltd Stock (INCR) Company Profile
Compare INCR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INCR
Intercure Ltd
|
1.40 | 76.32M | 118.18M | 5.99M | -12.91M | 0.1319 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Intercure Ltd Stock (INCR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-18-22 | Upgrade | Canaccord Genuity | Speculative Buy → Buy |
Intercure Ltd Stock (INCR) Latest News
Why InterCure Ltd. stock attracts global investorsNew Guidance & AI Powered Market Trend Analysis - newser.com
Volatility clustering patterns for InterCure Ltd.Market Growth Summary & Weekly Breakout Watchlists - newser.com
Is it time to cut losses on InterCure Ltd.Dip Buying & Stepwise Trade Signal Implementation - newser.com
Analyzing drawdowns of InterCure Ltd. with statistical toolsQuarterly Profit Report & Growth Focused Entry Reports - newser.com
Technical signs of recovery in InterCure Ltd.July 2025 Weekly Recap & Weekly Breakout Stock Alerts - newser.com
How InterCure Ltd. stock benefits from tech adoptionGlobal Markets & Community Trade Idea Sharing Platform - newser.com
Using data models to predict InterCure Ltd. stock movementSwing Trade & Real-Time Market Sentiment Reports - newser.com
Real time scanner hits for InterCure Ltd. explainedOptions Play & Real-Time Volume Spike Alerts - newser.com
Will InterCure Ltd. stock recover after recent dropDollar Strength & Free High Accuracy Swing Entry Alerts - newser.com
Applying Wyckoff theory to InterCure Ltd. stockJuly 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com
News impact scoring models applied to InterCure Ltd.New Guidance & Free Technical Pattern Based Buy Signals - newser.com
Can swing trading help recover from InterCure Ltd. lossesJuly 2025 Institutional & Safe Capital Investment Plans - newser.com
What sentiment indicators say about InterCure Ltd. stockJuly 2025 Setups & Technical Confirmation Trade Alerts - newser.com
Is InterCure Ltd. stock recession proofJuly 2025 Analyst Calls & Weekly Chart Analysis and Trade Guides - newser.com
Will InterCure Ltd. price bounce be sustainableJuly 2025 PostEarnings & Community Verified Trade Signals - newser.com
Will InterCure Ltd. stock outperform international peersWeekly Trade Review & Daily Chart Pattern Signal Reports - newser.com
What technical models suggest about InterCure Ltd.’s comebackPortfolio Return Report & Free Expert Approved Momentum Trade Ideas - newser.com
Is InterCure Ltd. stock cheap at current valuationWeekly Earnings Recap & Proven Capital Preservation Tips - newser.com
Can InterCure Ltd. stock beat market expectations this quarter2025 AllTime Highs & Stepwise Trade Signal Implementation - newser.com
Sentiment analysis tools applied to InterCure Ltd.July 2025 Earnings & Verified High Yield Trade Plans - newser.com
Intercure Ltd Stock (INCR) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.18%
1.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):